[Serological evaluation of an antimeningococcal mass vaccination campaign in Niger].
Authors searched by mean of radio-immuno-essay A and C anti-meningococcal antibodies in two villages from Niger (181 and 92 patients) in a meningitidis endemic area, which one profited 10 months ago of a mass vaccination campaign (A and C polysaccharides). A and C antibodies quantities and percentages of protected patients are not significantly different between the two villages. In one hand anti-C levels increase with patients age. In the other hand, there is a correlation between C meningococcal antibodies and anti-Hbc antibodies.
Rey
J L
JL
CERMES Niamey actuellement ORSTOM, Montpellier.
Soubiran
G
G
Fayet
M T
MT
Triau
R
R
D000293:Adolescent; D000328:Adult; D000942:Antigens, Bacterial / Q000032:analysis; D001428:Bacterial Vaccines / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008403:Mass Screening; D008589:Meningococcal Infections / Q000517:prevention & control*; D022401:Meningococcal Vaccines; D009345:Neisseria meningitidis / Q000276:immunology; D009548:Niger; D011135:Polysaccharides, Bacterial / Q000032:analysis; D015397:Program Evaluation
D000942:Antigens, Bacterial; D001428:Bacterial Vaccines; D022401:Meningococcal Vaccines; D011135:Polysaccharides, Bacterial; C043226:meningococcal group A polysaccharide; C037676:meningococcal group C polysaccharide
Evaluation sérologique d'une campagne de vaccination antiméningococcique de masse au Niger.